老虎证券

BUZZ-PTC Therapeutics falls after withdrawing muscle disorder drug marketing application

Reuters
02/13
BUZZ-PTC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> falls after withdrawing muscle disorder drug marketing application

** Shares of PTC Therapeutics PTCT.O fall 5.2% to $67.05 after markets

** Co says it has withdrawn its marketing application resubmission for its muscle disorder drug Translarna

** "FDA shared that based on its review to date, the data in the NDA submission are unlikely to meet the agency's threshold of substantial evidence of effectiveness to support approval of Translarna", says PTCT

** Last year co said the drug will no longer be available for sale in the EU as the European Commission has decided not to renew its marketing authorization

** The drug is designed to boost production of a protein called dystrophin, the absence of which causes muscle weakening in patients with Duchenne muscular dystrophy

** PTCT was up 68.3% in 2025

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10